e 4031 has been researched along with Hypertrophy, Left Ventricular in 1 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, XL | 1 |
| Zhao, LY | 1 |
| Wu, BW | 1 |
1 other study available for e 4031 and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
E-4031 enhanced Ca2+ transient and ventricular myocytes contraction via reverse mode Na+/Ca2+ exchange in normal and hypertrophic rats.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Electric Stimulation; Hypertrophy, Left Ventricular; Myoca | 2002 |